Global Hepatic Encephalopathy (HE) Therapeutics Market Research Report 2023

Report ID: 1988993 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Lactulose
        1.2.3 Rifaximin
        1.2.4 Neomycin
        1.2.5 Probiotics
        1.2.6 Thiamine
    1.3 Market by Application
        1.3.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Acute Liver Failure
        1.3.3 Liver Cirrhosis
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Perspective (2017-2028)
    2.2 Hepatic Encephalopathy (HE) Therapeutics Growth Trends by Region
        2.2.1 Hepatic Encephalopathy (HE) Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Hepatic Encephalopathy (HE) Therapeutics Historic Market Size by Region (2017-2022)
        2.2.3 Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Region (2023-2028)
    2.3 Hepatic Encephalopathy (HE) Therapeutics Market Dynamics
        2.3.1 Hepatic Encephalopathy (HE) Therapeutics Industry Trends
        2.3.2 Hepatic Encephalopathy (HE) Therapeutics Market Drivers
        2.3.3 Hepatic Encephalopathy (HE) Therapeutics Market Challenges
        2.3.4 Hepatic Encephalopathy (HE) Therapeutics Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Hepatic Encephalopathy (HE) Therapeutics Players by Revenue
        3.1.1 Global Top Hepatic Encephalopathy (HE) Therapeutics Players by Revenue (2017-2022)
        3.1.2 Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Players (2017-2022)
    3.2 Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Hepatic Encephalopathy (HE) Therapeutics Revenue
    3.4 Global Hepatic Encephalopathy (HE) Therapeutics Market Concentration Ratio
        3.4.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Hepatic Encephalopathy (HE) Therapeutics Revenue in 2021
    3.5 Hepatic Encephalopathy (HE) Therapeutics Key Players Head office and Area Served
    3.6 Key Players Hepatic Encephalopathy (HE) Therapeutics Product Solution and Service
    3.7 Date of Enter into Hepatic Encephalopathy (HE) Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Type
    4.1 Global Hepatic Encephalopathy (HE) Therapeutics Historic Market Size by Type (2017-2022)
    4.2 Global Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Type (2023-2028)
5 Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Application
    5.1 Global Hepatic Encephalopathy (HE) Therapeutics Historic Market Size by Application (2017-2022)
    5.2 Global Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Hepatic Encephalopathy (HE) Therapeutics Market Size (2017-2028)
    6.2 North America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2017-2022)
    6.3 North America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Hepatic Encephalopathy (HE) Therapeutics Market Size (2017-2028)
    7.2 Europe Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2017-2022)
    7.3 Europe Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size (2017-2028)
    8.2 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2017-2022)
    8.3 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size (2017-2028)
    9.2 Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2017-2022)
    9.3 Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size (2017-2028)
    10.2 Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2017-2022)
    10.3 Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 ASKA Pharmaceutical
        11.1.1 ASKA Pharmaceutical Company Detail
        11.1.2 ASKA Pharmaceutical Business Overview
        11.1.3 ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Introduction
        11.1.4 ASKA Pharmaceutical Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022)
        11.1.5 ASKA Pharmaceutical Recent Development
    11.2 COSMO PHARMACEUTICALS
        11.2.1 COSMO PHARMACEUTICALS Company Detail
        11.2.2 COSMO PHARMACEUTICALS Business Overview
        11.2.3 COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Introduction
        11.2.4 COSMO PHARMACEUTICALS Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022)
        11.2.5 COSMO PHARMACEUTICALS Recent Development
    11.3 Mallinckrodt
        11.3.1 Mallinckrodt Company Detail
        11.3.2 Mallinckrodt Business Overview
        11.3.3 Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Introduction
        11.3.4 Mallinckrodt Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022)
        11.3.5 Mallinckrodt Recent Development
    11.4 Valeant
        11.4.1 Valeant Company Detail
        11.4.2 Valeant Business Overview
        11.4.3 Valeant Hepatic Encephalopathy (HE) Therapeutics Introduction
        11.4.4 Valeant Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022)
        11.4.5 Valeant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Lactulose
    Table 3. Key Players of Rifaximin
    Table 4. Key Players of Neomycin
    Table 5. Key Players of Probiotics
    Table 6. Key Players of Thiamine
    Table 7. Global Hepatic Encephalopathy (HE) Therapeutics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Hepatic Encephalopathy (HE) Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Hepatic Encephalopathy (HE) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Region (2017-2022)
    Table 11. Global Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Region (2023-2028)
    Table 13. Hepatic Encephalopathy (HE) Therapeutics Market Trends
    Table 14. Hepatic Encephalopathy (HE) Therapeutics Market Drivers
    Table 15. Hepatic Encephalopathy (HE) Therapeutics Market Challenges
    Table 16. Hepatic Encephalopathy (HE) Therapeutics Market Restraints
    Table 17. Global Hepatic Encephalopathy (HE) Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Players (2017-2022)
    Table 19. Global Top Hepatic Encephalopathy (HE) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatic Encephalopathy (HE) Therapeutics as of 2021)
    Table 20. Ranking of Global Top Hepatic Encephalopathy (HE) Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Hepatic Encephalopathy (HE) Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Hepatic Encephalopathy (HE) Therapeutics Product Solution and Service
    Table 24. Date of Enter into Hepatic Encephalopathy (HE) Therapeutics Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Hepatic Encephalopathy (HE) Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Type (2017-2022)
    Table 28. Global Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Type (2023-2028)
    Table 30. Global Hepatic Encephalopathy (HE) Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Application (2017-2022)
    Table 32. Global Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Application (2023-2028)
    Table 34. North America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. ASKA Pharmaceutical Company Detail
    Table 45. ASKA Pharmaceutical Business Overview
    Table 46. ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Product
    Table 47. ASKA Pharmaceutical Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022) & (US$ Million)
    Table 48. ASKA Pharmaceutical Recent Development
    Table 49. COSMO PHARMACEUTICALS Company Detail
    Table 50. COSMO PHARMACEUTICALS Business Overview
    Table 51. COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Product
    Table 52. COSMO PHARMACEUTICALS Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022) & (US$ Million)
    Table 53. COSMO PHARMACEUTICALS Recent Development
    Table 54. Mallinckrodt Company Detail
    Table 55. Mallinckrodt Business Overview
    Table 56. Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Product
    Table 57. Mallinckrodt Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022) & (US$ Million)
    Table 58. Mallinckrodt Recent Development
    Table 59. Valeant Company Detail
    Table 60. Valeant Business Overview
    Table 61. Valeant Hepatic Encephalopathy (HE) Therapeutics Product
    Table 62. Valeant Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022) & (US$ Million)
    Table 63. Valeant Recent Development
    Table 64. Research Programs/Design for This Report
    Table 65. Key Data Information from Secondary Sources
    Table 66. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Lactulose Features
    Figure 3. Rifaximin Features
    Figure 4. Neomycin Features
    Figure 5. Probiotics Features
    Figure 6. Thiamine Features
    Figure 7. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Application in 2021 & 2028
    Figure 8. Acute Liver Failure Case Studies
    Figure 9. Liver Cirrhosis Case Studies
    Figure 10. Hepatic Encephalopathy (HE) Therapeutics Report Years Considered
    Figure 11. Global Hepatic Encephalopathy (HE) Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Hepatic Encephalopathy (HE) Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Region: 2021 VS 2028
    Figure 14. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Players in 2021
    Figure 15. Global Top Hepatic Encephalopathy (HE) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatic Encephalopathy (HE) Therapeutics as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Hepatic Encephalopathy (HE) Therapeutics Revenue in 2021
    Figure 17. North America Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Hepatic Encephalopathy (HE) Therapeutics Market Share by Country (2017-2028)
    Figure 19. United States Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Hepatic Encephalopathy (HE) Therapeutics Market Share by Country (2017-2028)
    Figure 23. Germany Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Share by Region (2017-2028)
    Figure 31. China Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Hepatic Encephalopathy (HE) Therapeutics Market Share by Country (2017-2028)
    Figure 39. Mexico Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Share by Country (2017-2028)
    Figure 43. Turkey Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. ASKA Pharmaceutical Revenue Growth Rate in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022)
    Figure 46. COSMO PHARMACEUTICALS Revenue Growth Rate in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022)
    Figure 47. Mallinckrodt Revenue Growth Rate in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022)
    Figure 48. Valeant Revenue Growth Rate in Hepatic Encephalopathy (HE) Therapeutics Business (2017-2022)
    Figure 49. Bottom-up and Top-down Approaches for This Report
    Figure 50. Data Triangulation
    Figure 51. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
ASKA Pharmaceutical
COSMO PHARMACEUTICALS
Mallinckrodt
Valeant
Frequently Asked Questions
Hepatic Encephalopathy (HE) Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hepatic Encephalopathy (HE) Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hepatic Encephalopathy (HE) Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hepatitis Drugs

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More

Herbal Cigarette

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More